How can Medable enhance its eConsent module to improve patient comprehension of clinical trial information?

Introduction

To enhance Medable's eConsent module for improved patient comprehension of clinical trial information, we need to focus on user-centric design, leveraging technology, and addressing key pain points in the consent process. I'll approach this challenge by analyzing user segments, identifying pain points, generating solutions, and proposing metrics for success.

Step 1

Clarifying Questions (5 mins)

• Looking at the product context, I'm thinking Medable's eConsent module might be at a critical stage where regulatory compliance and user experience are equally important. Could you help me understand the current balance between compliance requirements and user-friendly design in the eConsent module?

Why it matters: Determines if we need to focus more on simplifying complex information or enhancing interactive elements. Expected answer: Compliance is well-addressed, but user experience needs improvement. Impact on approach: Would focus on innovative ways to present information while maintaining compliance.

• Considering user behavior, I'm curious about how patients typically interact with the eConsent module. Are they primarily accessing it through mobile devices, desktops, or both? And do we have data on average completion times and dropout rates?

Why it matters: Helps tailor the solution to the most common use cases and identify potential friction points. Expected answer: Primarily mobile access with high dropout rates on complex sections. Impact on approach: Would prioritize mobile-first design and breaking down complex information into digestible chunks.

• Regarding product lifecycle and company alignment, where does improving patient comprehension in the eConsent module fit within Medable's broader strategic goals? Are there specific metrics or outcomes the company is aiming to achieve?

Why it matters: Ensures our solution aligns with overall company objectives and helps prioritize features. Expected answer: Key strategic priority with goals to increase trial enrollment rates and reduce time-to-start for clinical trials. Impact on approach: Would focus on solutions that not only improve comprehension but also streamline the consent process.

• In terms of external factors, how has the competitive landscape evolved recently? Are there any emerging technologies or approaches in eConsent that we should be considering?

Why it matters: Identifies opportunities for differentiation and innovation. Expected answer: Competitors are exploring AI-driven explanations and gamification elements. Impact on approach: Would consider incorporating cutting-edge technologies while ensuring they truly enhance comprehension.